SGLT2 inhibition in cardiology: what is the profile of benefit? .
Topic:
Diabetes and the Heart
Speaker:
Professor N. Marx (Aachen, DE)
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly
Event:
ESC Congress 2018
Congress Presentation
About the speaker
Professor Nikolaus Marx
RWTH University Hospital Aachen, Aachen (Germany)
52
presentations
11
followers
4 more presentations in this session
Introduction - Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure.
Speaker: Professor F. Cosentino (Stockholm, SE)
Changing focus in diabetes: From glucose to cardiovascular risk management.
Speaker: Professor S. Jacob (Villingen, DE)
Heart failure & SGLT2: with or without diabetes?
Speaker: Professor J. McMurray (Glasgow, GB)
Discussion - Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure.
Speaker: Professor F. Cosentino (Stockholm, SE)
Access the full session
Targeting SGLT2 in clinical cardiology: exploring the benefits in cardiovascular risk, diabetes & heart failure (EBAC Accredited)
Speakers:
Professor N. Marx, Professor F. Cosentino, Professor S. Jacob, Professor J. McMurray, Professor F. Cosentino
About the event
